Cosmetics packaged in ampoules, vials, and syringes will be required to bear the warning “Injection is prohibited. Cosmetics are for external use only” in red on both primary and secondary packaging.
From October 11 to 27, 2023, the Thai Food and Drug Administration (Thai FDA) conducted a public consultation to gather feedback on proposed labeling regulations for ampoule, vial, and syringe cosmetics. This draft spells out essential requirements for labeling, including the necessary content, position, language, and other pertinent details.
We provide full-scale global cosmetic market entry services (including cosmetic registering & filing, regulatory consultation, customized training, market research, branding strategy). Please contact us to discuss how we can help you by cosmetic@chemlinked.com
Thailand Revises Notification Review Standard for Ampoule, Vial, and Syringe Cosmetics
CSAR Subsidiary Regulations: China Consults on the Draft Administrative Measures on Cosmetics Labeling
China Consults on Technical Guidelines for Children Cosmetics: Stricter Ingredient Use and Labeling Requirements
Under the current regulatory framework, cosmetics registrants and notifiers can continue to submit a simplified version of the safety assessment report during the registration or notification process until May 1, 2025. Following this deadline, a full version of the safety assessment will be mandated. To facilitate a smooth transition, China is planning to release a set of technical guidelines.
The current cosmetic technical standard STSC 2015 specifies the cosmetics' general safety standards, prohibited/restricted/permitted ingredients and testing methods. It is revised aperiodically in response to changing trade practices in the industry. China is planning to issue a new version of STSC.
